Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Midatech Pharma plc
  6. News
  7. Summary
    MTPH   GB00BKT14T00

MIDATECH PHARMA PLC

(MTPH)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Maintaining Modest Thursday Advance

06/17/2021 | 01:26pm EDT


© MT Newswires 2021
All news about MIDATECH PHARMA PLC
07/21MIDATECH PHARMA : welcomes Dr Dmitry Zamoryakhin as Chief Scientific Officer
AQ
07/12Midatech Pharma plc Announces Executive Changes
CI
06/29MIDATECH PHARMA : UK Placing to Raise £10.0 million (Form 6-K)
PU
06/29FTSE 100 Rises 0.3% as Construction Stocks Gain
DJ
06/29MIDATECH PHARMA : Corporate Overview
PU
06/29FTSE 100 Tipped to Open Lower After Mixed Asia, U.S. Sessions
DJ
06/17SECTOR UPDATE : Health Care Stocks Add to Afternoon Gains
MT
06/17SECTOR UPDATE : Health Care Stocks Maintaining Modest Thursday Advance
MT
06/17Wall Street Set for Losses on Fed-Induced Weakness
MT
06/17MIDATECH PHARMA : Breakthrough data on the successful encapsulation of a biologi..
PU
More news
Financials
Sales 2020 0,34 M 0,47 M 0,47 M
Net income 2020 -22,2 M -30,5 M -30,5 M
Net cash 2020 7,21 M 9,91 M 9,91 M
P/E ratio 2020 -0,51x
Yield 2020 -
Capitalization 26,8 M 36,9 M 36,9 M
EV / Sales 2019 13,7x
EV / Sales 2020 27,7x
Nbr of Employees 18
Free-Float 87,0%
Chart MIDATECH PHARMA PLC
Duration : Period :
Midatech Pharma plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MIDATECH PHARMA PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 1
Last Close Price 0,27 
Average target price
Spread / Average Target -
Managers and Directors
Stephen Anthony Stamp Director, Chief Executive & Financial Officer
Rolf Stahel Non-Executive Chairman
Steve Damment Head-Research & Development
Sijmen de Vries Independent Non-Executive Director
Simon Turton Senior Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MIDATECH PHARMA PLC2.83%30
GILEAD SCIENCES, INC.17.83%85 134
WUXI APPTEC CO., LTD.37.17%71 226
REGENERON PHARMACEUTICALS21.48%57 013
BIONTECH SE244.68%55 555
VERTEX PHARMACEUTICALS-17.06%50 308